AbbVie shares took a dip on Wednesday after it was announced that the pharma giant would be facing a lawsuit from the California Department of Insurance in regards to allegedy kickbacks given…
Chris Lange The August 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
The August 15 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical stocks was mixed.
Big Pharma is looking good for investors in the second half of 2018. That's the message from the research team at Bank of America Merrill Lynch.
The latest monthly Merrill Lynch RIC Report is quite favorable on the health care sector as an opportunity for investors. Here we identify some of the top health care picks.
The July 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
AbbVie released a better-than-expected quarterly report early on Friday, but shares retreated afterward.
Chris Lange The July 13 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
24/7 Wall St. has put together a preview of AbbVie, Eli Lilly, Gilead Sciences and some of the other, larger health care companies that are about to report their quarterly results.
Four pharmaceutical industry leaders are poised to report second-quarter results next week, and one key analyst sees the relatively good print from Johnson & Johnson as a good signal for the group…
The top analyst upgrades, downgrades and other research calls from Thursday include AbbVie, Amazon.com, Anadarko, Broadcom, Chipotle Mexican Grill, ConocoPhiilips, General Electric, Honeywell, Johnson & Johnson, 3M, NetApp and Netflix.
The June 29 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
AbbVie shares dipped on Wednesday after the company gave a less than impressive update from its late-stage lymphoma trial.
Chris Lange Here 24/7 Wall St. has included a calendar of some of the biggest companies expecting clinical trial and FDA updates in July.
The June 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
